Masonic Cancer Center, University of Minnesota

What's Inside

Quick Links for:

Cancer Information Line
Ask about cancer, clinical trials, and how to make an appointment:
ccinfo@umn.edu
612-624-2620

Toll-free in IA, MN, ND, SD, WI: 1-888-CANCER MN
(1-888-226-2376)

A Comprehensive Cancer Center Designated by the National Cancer Institute

Print this page. Mail this link to a friend.

Cancer Center Seminar Series 2005-2006


DATE
TOPIC
SPEAKER
HOST
09/13/05
Notch signaling in leukemia: New insights

Jon C. Aster, M.D., Ph.D.

Associate Professor

Department of Pathology

Harvard Medical School

Hematopathology Training Program

Brigham and Women's Hospital

Director, Hematopathology Core

DanaFarber/Harvard Comprehensive Cancer Center

Tucker LeBien
09/20/05
Cancer genetic screens using the Sleeping Beauty transposon

David A. Largaespada, Ph.D. Associate Professor Department of Genetics, Cell Biology & Development Program Leader Genetic Mechanisms of Cancer Program University of Minnesota Cancer Center

 
09/27/05
Discovery of a predictive marker for supersensitivity to adjuvant
Herceptin in breast cancer

  Soonmyung Paik, M.D.

Director, Pathology Section

National Surgical Adjuvant Breast and Bowel Project

Doug Yee
10/04/05
Identification of a novel small-molecule inhibitor for the hypoxia-inducible factor (HIF-1) pathway

Chalet Tan, Ph.D.

Assistant Professor

Department of Pharmacy Practice and Pharmaceutical Sciences

College of Pharmacy

University of Minnesota-Duluth
 
10/11/05
 Causes of childhood cancer: Where to next?

  Julie Ross, Ph.D.

Professor and Director

Division of Pediatric Epidemiology & Clinical Research

Department of Pediatrics

Associate Director

University of Minnesota Cancer Center

 
10/18/05
A multi pronged approach to cancer immunotherapy using mRNA transfected dendritic cells

Eli Gilboa, Ph.D.

Professor and Director

Center for Genetic and Cellular Therapies

Department of Surgery

Duke University Medical Center

Wei Chen

10/25/05
 Retroviral insertional mutagenesis
insights into human and mouse hematopoietic disease

Neal Copeland, Ph.D.

Head, Molecular Genetics of Oncogenesis Section

Mouse Cancer Genetics Program

National Cancer Institute

Frederick, MD

Rachel Saplis/MICaB
11/01/05
  HSP90-directed therapy: Attack on a chaperone

Charles Erlichman, M.D., F.A.C.P., F.R.C.P.C.

Chair, Department of Oncology
Deputy Director for Clinical Affairs
Mayo Clinic Cancer Center

John Kersey

11/08/05
IDO, tolerance and regulatory T cells

David Munn, M.D.

Professor

Pediatric Hematology/Oncology

Medical College of Georgia

Bruce Blazar
11/15/05

The role of the AML1/CBF beta transcription factor complex in normal hematopoieisis

James R. Downing, M.D. Scientific Director Chairman, Department of Pathology St. Jude Children's Research Hospital Memphis, TN 

Dan Kaufman

11/22/05
Telomerase inhibition and osseous androgen-independent prostate cancer
Kenneth Koeneman, M.D. Dougherty Endowed Chair in Urologic Oncology
Director, Center for Prostate Cancer Department of Urology
University of Minnesota

 

11/29/05

How do T cells activate integrins?

Yoji Shimizu, Ph.D.

Professor

Department of Laboratory Medicine and Pathology

Program Leader

Cancer Center Immunology Program

University of Minnesota

 

12/06/05
A genetic approach to unraveling diabetes

Jennifer Hall, Ph.D.

Assistant Professor

Department of Medicine

Lillihei Heart Institute

University of Minnesota

 

12/13/05

NO SEMINAR DUE TO ASH MEETING

 

 

12/20/05
 Regulation of breast cell differentiation and gene expression by mechanical signaling from collagen matrices

Patricia J. Keely, Ph.D.

Assistant Professor

Department of Pharmacology

University of Wisconsin-Madison

 

Yoji Shimizu

12/27/05
SEMINAR CANCELLED DUE TO HOLIDAYS

  

 

01/03/06 SEMINAR CANCELLED DUE TO HOLIDAYS    
01/10/06

Cell and molecular biology of HIV and HTLV:  implications for cancer etiology, therapeutics and prevention

Louis M. Mansky, Ph.D.

Associate Professor

Departments of Microbiology and Oral Sciences

Director Institute for Molecular Virology University of Minnesota

 

01/17/06

Targeting of 6-phosphofructo-2-kinase in cancer

Jason Chesney, MD., Ph.D.

Assistant Professor

Department of Medicine

Department of Toxicology and Pharmacology

James Graham Brown Cancer Center

University of Louisville

 

Alex Lange

01/24/06
Convergence of the catenin p120ctn and the  transcription factor Kaiso on target genes of the Wnt/Beta-catenin/TCF pathway

 

Juliet M. Daniel, Ph.D.
Associate Professor
Department of Biology
McMaster University
Hamilton, Ontario

 

 Jen Westendorf
01/31/06

Breast cancer in Asian Americans

Anna H. Wu, Ph.D.

Professor

Department of Preventive Medicine

Keck School of Medicine

University of Southern California

Mimi Yu
02/07/06

Development of profiles for lung cancer diagnosis and prognosis

David G. Beer, Ph.D.

Professor

Department of Surgery, Thoracic Section

Department of Radiation Oncology

University of Michigan

Ann Arbor, MI

Robert Kratzke
02/14/06

Mechanisms of peptide/MHC class I presentation pathway

Nilabh Shastri, Ph.D.

Professor of Immunology

Department of Molecular and Cellular Biology

University of California-Berkeley

S. Ramakrishnan

02/21/06

Oncolytic viruses: Turning one human enemy against the other!

Faris Farassati, Ph.D., PharmD

Assistant Professor

Department of Medicine - Division of Hematology, Oncology and Transplantation

University of Minnesota

02/28/06

The hematopoietic microenvironment in health and disease

Russell S. Taichman D.M.D., D.M.Sc. Associate Professor Department of Periodontics/Prevention/Geriatrics University of Michigan School of Dentistry Ann Arbor, Michigan

Raj Gopalakrishnan

03/07/06

Translational development of novel therapies for malignant brain tumors

 

  John Ohlfest, Ph.D.

Assistant Professor

Director, Translational Gene Therapy Program
Director, Gene and Stem Cell Core Facility

Department of Neurosurgery

University of Minnesota

 

03/14/06

The molecular basis of reovirus oncolysis

Patrick Lee, Ph.D. Professor

Department of Microbiology and Immunology Cameron Chair in Cancer Research Faculty of Medicine Dalhousie University Halifax, Nova Scotia, Canada

Faris Farassati

03/21/06
Gene expression programs of development and cancer: Connections and
disconnections in prostate carcinogenesis

 

Peter Nelson, M.D.

Division of Human Biology

Fred Hutchinson Cancer Research Center

Seattle, WA

Paul Marker

03/28/06

Determinant of sex hormones linked to prostate cancer in Black and white men: Results of the CARDIA male hormone study

 Susan M. Gapstur, Ph.D., M.P.H.

Associate Professor
Department of Preventive Medicine
Northwestern University

Julie Ross

04/04/06

NO SEMINAR DUE TO AACR ANNUAL MEETING

 

 

04/11/06
Role of cell death in modulating tumorigenesis and chemotherapy

 

Eileen White, Ph.D. Professor

Molecular Biology and Biochemistry

Rutgers University

Associate Director for Basic Science, The Cancer Institute of New Jersey

 

Ameeta Kelekar

04/18/06

Update of Gene Based Vaccines in NSCLC

John Nemunaitis, M.D .

Executive Director of the Mary Crowley Medical Research Center

Scott McIvor

04/25/06
The
transcription factor ZEB1 in uterine cancers

  Jennifer Richer, Ph.D.

Assistant Professor

Department of Medicine

University of Colorado Health Sciences Center

 Carol Lange
05/02/06
Genes, vaccines, and immune checkpoints:  How the molecular revolution is
changing tumor immunology and immunotherapy

 

Elizabeth M. Jaffee, M.D. Professor of Oncology, Immunology, and Cell and Molecular Medicine The Dana and Albert Broccoli Professor of Oncology The Sidney Kimmel Comprehensive Cancer Center

Johns Hopkins University

Xianzheng Zhou

05/09/06

Women’s hormones: Breast cancer growth and metastasis

Kathryn B. Horwitz, Ph.D.

Distinguished Professor

University of Colorado Health Sciences Center

Carol Lange

05/16/06
Role of Myeloid Translocation Gene family 
members in acute leukemia and stem cell functions

Scott Hiebert, Ph.D.

Professor

Department of Biochemistry 

Vanderbilt University

 

Jennifer Westendorf

05/23/06
Lifestyle influence on breast cancer risk and recurrence

Rowan T. Chlebowski, M.D., Ph.D. Professor of Medicine David Geffen School of Medicine at UCLA Chief, Division of Medical Oncology and Hematology Harbor-UCLA Medical Center

Alice Shapiro

Co-Sponsored by the Minnesota Obesity Center